German and U.S. scientists win Nobel medicine prize for work on optogenetics
German scientist Peter Hegemann and American scientist Karl Deisseroth, along with German scientist Georg Nagel, were awarded the 2026 Nobel Prize in Physiology or Medicine for their pioneering work in optogenetics. Their research focused on light-gated ion channels, which allow scientists to control the activity of individual nerve cells in living brains. This breakthrough technology is already being used in clinical trials to restore vision in patients with retinitis pigmentosa and has potential applications in improving cochlear implants. The prize, worth 12 million Swedish crowns, recognizes their contributions to understanding the brain's function. The trio expressed surprise and delight upon receiving the award, highlighting their collaborative efforts and mutual respect.
German and U.S. scientists Karl Deisseroth, Peter Hegemann and Georg Nagel have won the 2026 Nobel Prize in Physiology or Medicine for their work on light-gated ion channels and optogenetics. The Nobel Assembly at Sweden's Karolinska Institute announced the award on Monday, citing the laureates' contributions to understanding how the brain functions through the use of light to control nerve cell activity. Thomas Perlmann, Secretary-General of the Nobel Assembly at Karolinska Institutet, stated that the winners were selected for their "discoveries concerning light-gated ion channels and optogenetics." According to Perlmann, optogenetics allows researchers to activate or deactivate individual nerve cells in a living brain. This technique is currently being used globally to explore the complexities of the brain. In clinical settings, researchers are applying optogenetics to restore vision in individuals affected by retinitis pigmentosa, a condition that causes blindness. They insert a light-sensitive protein into the retina to help regain sight. Additionally, scientists are exploring its potential to enhance cochlear implants, offering more precise stimulation of the auditory nerve compared to existing electrical devices. The Nobel Prize in Physiology or Medicine typically marks the beginning of the annual Nobel announcements, followed by awards in physics, chemistry, literature, peace and economics over the following days. Deisseroth, Hegemann and Nagel will share a total prize sum of 12 million Swedish crowns, equivalent to $1.2 million. Hegemann began investigating the alga Chlamydomonas in the early 1990s, studying how it reacts to light within half a millisecond. He proposed that a single protein captures light and acts as an ion channel. Nagel tested this hypothesis by injecting Chlamydomonas genes into frog eggs, leading to the discovery of channelrhodopsin-2, a protein that opens when exposed to light. In 2003, they published findings showing that this protein can be introduced into human and hamster cells to generate electrical impulses using light. By 2005, Deisseroth at Stanford University demonstrated the technique in rat nerve cells, and the method was subsequently named optogenetics. Perlmann mentioned that he spoke with each laureate earlier in the day and noted their surprise and delight at receiving the prize. All three expressed that they considered it an honor to be awarded alongside the others, referring to one another as friends. The Nobel Prizes have been awarded annually since 1901, with only minor interruptions during World War I and World War II. A sixth prize, the Economics Prize, was established in 1968 by Sweden's central bank, the Riksbank. The Nobel Prize in Physiology or Medicine has recognized several groundbreaking scientific achievements, including Alexander Fleming's discovery of penicillin in 1945 and Karl Landsteiner's identification of human blood groups in 1930. Last year, the prize was awarded to Mary Brunkow, Fred Ramsdell and Shimon Sakaguchi for their work on the immune system's ability to spare healthy cells, potentially opening new treatment avenues for diseases like cancer. Nobel laureates are selected by expert committees appointed by the respective prize-awarding institutions. The awards are presented in Stockholm, except for the Peace Prize, which is given in Oslo. These traditions continue more than 125 years after Alfred Nobel signed his will. The Nobel celebrations conclude on December 10, the anniversary of Nobel's death, when laureates attend ceremonies in Stockholm and Oslo, hosted by the royal families of Sweden and Norway, and participate in gala banquets in their honor.
2 reports
The Japan TimesIndependentCenterFactual: no official source document/info detectedObjective 9021 hr. ago
Three scientists, Karl Deisseroth, Peter Hegemann, and Georg Nagel, were awarded the 2026 Nobel Prize in Physiology or Medicine for their groundbreaking research on light-gated ion channels and optogenetics. Their work has significantly advanced neuroscience by enabling precise control over cellular activity using light. This technique has applications in studying brain function and developing treatments for neurological disorders. The award recognizes their contributions to understanding how cells respond to light stimuli at the molecular level.
Bias read (Center): The article reports on a scientific achievement without any political implications. It focuses solely on the recognition of scientific work and does not involve any politically charged topics such as government policies, elections, or social issues.
Why factuality: no official source document/info detected
Why objectivity (90): The article presents the news in a neutral tone, simply stating the facts without emotional language or bias. It does not take sides or express personal opinions about the significance of the research.
German scientist Peter Hegemann and American scientist Karl Deisseroth, along with German scientist Georg Nagel, were awarded the 2026 Nobel Prize in Physiology or Medicine for their pioneering work in optogenetics. Their research focused on light-gated ion channels, which allow scientists to control the activity of individual nerve cells in living brains. This breakthrough technology is already being used in clinical trials to restore vision in patients with retinitis pigmentosa and has potential applications in improving cochlear implants. The prize, worth 12 million Swedish crowns, recognizes their contributions to understanding the brain's function. The trio expressed surprise and delight upon receiving the award, highlighting their collaborative efforts and mutual respect.
Bias read (Center): The article presents a factual report on a scientific achievement without any political commentary or ideological framing. It focuses solely on the scientific contributions and recognition of the researchers, maintaining a neutral tone throughout.
How each side covered it
The same event, grouped by the political lean of the outlets covering it.
progressive
center
conservative
★
How each side covered it
Support independent, bias-aware news and unlock the social pulse, community voting, and every other Supporter feature.